Key result
Expression of connexin43 driven by the muscle creatine kinase (MCK) promoter delayed until after differentiation allowed skeletal myotubes to remain viable and express gap junction proteins after grafting into the heart.
Why the study?
Does gene transfer of Connexin43 using the MCK promoter improve viability and gap junction formation in skeletal myoblasts grafted into nude mouse hearts?
Population
Preclinical models including mouse myoblast lines, primary Fischer neonatal rat myoblasts, and adult male…
Comparison
Gene transfer of Connexin43 into skeletal… vs Control vectors or wild-type non-transfected…
Design
Preclinical
Follow-up
up to 4 weeks
Authors
Loading...
May improve myoblast viability in preclinical cardiac grafts; leaves open translation of MCK-driven connexin43 to cellular cardiomyoplasty.
Does gene transfer of Connexin43 using the MCK promoter improve viability and gap junction formation in skeletal myoblasts grafted into nude mouse hearts?
Using a differentiation-specific promoter (MCK) to overexpress Connexin43 in skeletal myoblasts prevents cell death and enables gap junction formation with host cardiomyocytes, advancing cellular cardiomyoplasty strategies.
Reinecke et al. (2004) studied Myocardial ischemia / Cellular cardiomyoplasty. Gene transfer of Connexin43 (Cx43) using MCK promoter vs. Empty vector / GFP-adenovirus / Constitutive viral promoters (LTR, CMV) was evaluated on Cell survival and Cx43 expression/gap junction formation after differentiation and grafting. Expression of connexin43 driven by the muscle creatine kinase (MCK) promoter delayed until after differentiation allowed skeletal myotubes to remain viable and express gap junction proteins after grafting into the heart.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: